Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2023 is 0.00% vs 0.00% in Sep 2022
Consolidate Net Profit
YoY Growth in quarter ended Sep 2023 is 52.00% vs 24.24% in Sep 2022
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2023 is 51.43% vs 30.00% in Sep 2022
Interest
YoY Growth in quarter ended Sep 2023 is -60.00% vs 150.00% in Sep 2022
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2023 has improved from Sep 2022
Compare Quarterly Results Of Eloxx Pharmaceuticals, Inc. With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2023 is 16.28% vs 30.65% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 52.00% vs 24.24% in Sep 2022
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2023 is 15.00% vs 24.53% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 51.43% vs 30.00% in Sep 2022
Quarterly - Interest
QoQ Growth in quarter ended Sep 2023 is 0.00% vs -60.00% in Jun 2023
YoY Growth in quarter ended Sep 2023 is -60.00% vs 150.00% in Sep 2022






